Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.12.19	Pfizer Declares First-Quarter 2020 Dividend and Announces Upcoming Investor Day to Highlight Strength of Innovative R&D Pipeline (Businesswire)
14.12.19	Are These Biotech Companies Buyout Candidates? Deal Or No Deal? (RTTNews)
13.12.19	Pfizer: CHMP Adopts Positive Opinion On VYNDAQEL - Quick Facts (RTTNews)
13.12.19	Pfizer Receives Positive CHMP Opinion for VYNDAQEL® for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease (Businesswire)
13.12.19	First Generic Version Of NuvaRing Gets FDA Nod, ONCT On Watch, SRPT Surges (RTTNews)
05.12.19	ViiV Healthcare Submits NDA To FDA For Fostemsavir On HIV-1 Infection (RTTNews)
02.12.19	Biotech Stocks Facing FDA Decision In December 2019 (RTTNews)
27.11.19	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
20.11.19	Biosimilar Race: U.S. Lags Behind Europe (RTTNews)
19.11.19	KRTX Makes Giant Leap, The Medicines' Working Well, AGRX On The Move (RTTNews)
18.11.19	FDA Approves Pfizer's ABRILADA, Fifth Biosimilar To Humira (RTTNews)
18.11.19	Pfizer: FDA Approves ABRILADA As Biosimilar To Humira - Quick Facts (RTTNews)
18.11.19	FDA Approves Pfizer’s Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions (Businesswire)
15.11.19	Bristol-Myers Squibb and Pfizer Announce Randomized, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals (Businesswire)
12.11.19	Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination (Businesswire)
29.10.19	Pfizer Q3 Profit Rises; Lifts 2019 Profit View (RTTNews)
29.10.19	Pfizer Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
29.10.19	PFIZER REPORTS THIRD-QUARTER 2019 RESULTS (Businesswire)
28.10.19	Biotech Stocks Facing FDA Decision In November 2019 (RTTNews)
14.10.19	ImaginAb, AstraZeneca, Pfizer, Takeda Join To Develop CD8 ImmunoPET Technology (RTTNews)
12.10.19	Pfizer Presents Positive Phase 3 Data at the 28th Congress of the European Academy of Dermatology and Venereology for Abrocitinib in Moderate to Severe Atopic Dermatitis (Businesswire)
30.09.19	Pfizer: Interim BEACON CRC Data Shows Encouraging Potential For BRAFTOVI Triplet (RTTNews)
27.09.19	Pfizer Inc. Awards "Golden Tickets” to Neutrolis and Mediar Therapeutics (Businesswire)
27.09.19	Pfizer Names CEO Albert Bourla To Succeed Ian Read As Chairman - Quick Facts (RTTNews)
27.09.19	Ian Read to Retire as Executive Chairman of Pfizer’s Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman (Businesswire)
27.09.19	Pfizer Announces Positive Top-Line Results On Abrocitinib (RTTNews)
24.09.19	Pfizer Declares Fourth-Quarter 2019 Dividend (Businesswire)
24.09.19	Pfizer Presents New Evidence of IBRANCE® (palbociclib) Effectiveness in HR+, HER2- Metastatic Breast Cancer Patients in Four Real-World Studies at ESMO Congress 2019 (Businesswire)
19.09.19	Pfizer Presents Scientific Advancements in Cancer Care at the ESMO Congress 2019 Highlighting Expanded Portfolio (Businesswire)
17.09.19	Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call With Analysts (Businesswire)
09.09.19	Pfizer Reports Positive Results From Phase 2 Study Of 20vPnC Vaccine Candidate (RTTNews)
03.09.19	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
22.08.19	Pfizer To Invest $500 Mln In Gene Therapy Manufacturing Plant (RTTNews)
21.08.19	U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer (Businesswire)
21.08.19	Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina (Businesswire)
16.08.19	Pfizer Recalls Migraine Tablets Over Concerns Of Bacterial Infection (RTTNews)
03.08.19	Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive Crisis (Businesswire)
01.08.19	AMRN'S Vascepa Hits Record Sales, ADMP Slumps On Stock Offering, SRDX On Watch… (RTTNews)
01.08.19	Pfizer Closes JV With GlaxoSmithKline, Forms GSK Consumer Healthcare (RTTNews)
01.08.19	Pfizer Announces Closing of Joint Venture With GlaxoSmithKline to Create a Premier Global Consumer Healthcare Company (Businesswire)
30.07.19	Pfizer Completes Acquisition of Array Biopharma (Businesswire)
29.07.19	Pfizer Acquires Mylan And The EpiPen (RTTNews)
29.07.19	Pfizer Q2 Revenues Up 2% Operationally; Updates 2019 Guidance (RTTNews)
29.07.19	Biotech Stocks Facing FDA Decision In August 2019 (RTTNews)
29.07.19	Mylan, Pfizer Upjohn To Combine To Create New Global Pharma Company (RTTNews)
29.07.19	Pfizer Inc. Reschedules Second-Quarter 2019 Earnings Conference Call to July 29, 2019 at 10:30 a.m. EDT (Businesswire)
29.07.19	PFIZER REPORTS SECOND-QUARTER 2019 RESULTS (Businesswire)
29.07.19	Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine (Businesswire)
29.07.19	GSK: ViiV Submits Regulatory Application To EMA For Cabotegravir HIV Injection (RTTNews)
28.07.19	Pfizer Reportedly In Talks To Merge Off-patent Assets With Mylan (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

20:03		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
18:01		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
17:58		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
17:58		Handel in Frankfurt: TecDAX letztendlich in Grün
17:58		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen
17:58		Gewinne in Frankfurt: SDAX zum Handelsende freundlich
17:58		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

20:03

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

18:01

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

17:58

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

17:58

Handel in Frankfurt: TecDAX letztendlich in Grün

17:58

Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

17:58

Gewinne in Frankfurt: SDAX zum Handelsende freundlich